Fingerprint
Dive into the research topics of 'Phase II trial of the glycoprotein non-metastatic B-targeted antibody–drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology Group'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically